Australia's Noxopharm scales up production of lupus medication
Australian biotech company Noxopharm is scaling up production of its preclinical SOF-SKN lupus medication to the quality standards that will be required for upcoming regulatory submissions. In a significant inflection point, SOF-SKN has now reached the …